secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001213900-25-098281
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics raises $4.5M in private placement of stock and warrants
---------------------------------------------------------------------------

- Gross proceeds of $4.5M; net proceeds ~$4.0M after 8% placement agent fee and expenses.
- Issued 2.25M shares/pre-funded warrants at $2.00/unit plus Series F warrants for 4.5M shares at $1.75.
- Net proceeds to fund FDA approval efforts, clinical studies, R&D, and working capital.
- Rodman & Renshaw acted as exclusive placement agent; warrants include 4.99%/9.99% beneficial ownership caps.
- Company agreed to file resale registration statement by Oct 24, 2025, and has 90-day issuance lock-up post-effectiveness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/ea0260965-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-098281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer